Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124776052 | 12477605 | 2 | F | 20160504 | 20160623 | 20160617 | 20160711 | PER | US-BAYER-2016-117319 | BAYER | 82.00 | YR | E | F | Y | 69.39000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124776052 | 12477605 | 1 | PS | CLARITIN | LORATADINE | 1 | Oral | 1 DF, QD | CVM03EK | 19658 | 1 | DF | TABLET | QD | |||||
124776052 | 12477605 | 2 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | UNK | 0 | |||||||||||
124776052 | 12477605 | 3 | C | ATENOLOL. | ATENOLOL | 1 | UNK | 0 | |||||||||||
124776052 | 12477605 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124776052 | 12477605 | 1 | Sinusitis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124776052 | 12477605 | Dysphonia | |
124776052 | 12477605 | Headache | |
124776052 | 12477605 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124776052 | 12477605 | 1 | 20160503 | 20160614 | 0 |